Dana Farber Cancer Institute — Boston, Massachusetts

Dana Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute has participated in 1291 clinical trials with 467 currently active.

Therapeutic areas: Metastatic Castration Resistant Prostate Cancer (mCRPC), Endometrial Cancer, Waldenstrom Macroglobulinemia.

Sponsors: Constellation Pharmaceuticals, Fred Hutchinson Cancer Center, Jorge J. Castillo, MD.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute?

Dana Farber Cancer Institute has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute conducted?

Dana Farber Cancer Institute has 1291 clinical trials on record, with 467 currently active. Their work covers Metastatic Castration Resistant Prostate Cancer (mCRPC), Endometrial Cancer, Waldenstrom Macroglobulinemia.

Is Dana Farber Cancer Institute accredited by Crixeo Health?

Dana Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.